Age and Comorbidities as The Main Factors of Mortality in Covid-19 Patients : A Retrospective Cohort Study

Anni Fithriyatul Mas’udah, Lina Ema Purwanti, Hery Ernawati, Naylil Mawadda Rohma, Vanesha Awaliya Muslimah, Vanesya Isnaya Muslimah

Abstract


Background: The high mortality rate in COVID-19 patients is associated with demographic factors and comorbid conditions. This is supported by research which shows that a history of comorbidities causes 88% of deaths in SARS-CoV-2 positive patients.Consequently, it is important to identify factors associated with poor outcomes among COVID-19 patients.

Objective: The purpose of this study was to determine the main factors that cause COVID-19 mortality in Indonesia.

Methods: The research design used a retrospective cohort. The population of this study was all Covid-19 patients treated at the 'Aisiyah Ponorogo General Hospital from March to December 2021, totalling 881. The data was arrangedbased on the completeness of the medical records, and seven respondents had to be excluded due to incomplete data. Therefore, the total number of samples used was 874 patients. Data was analyzed using logistic regression.

Result: The multivariate analysis showed that patients aged 46-65 years were 1.45 times greater potential to die than than patients who were 0-25 years old.  The risk factors for comorbidities had an effect on the mortality of patients with confirmed cases of COVID-19.The variables that had a significant effect on the mortality of COVID-19 included Diabetes mellitus (OR=1.36), Hypertension (OR = 1.78) and heart disease (OR = 1.4).

Conclusion: The most common causes of mortality in Covid-19 patients are age and comorbidities diseases, there are diabetes mellitus, hypertension and heart disease


Keywords


age; comorbidities; mortality; COVID-19

Full Text:

PDF

References


Bajgain, K. T., Badal, S., Bajgain, B. B., & Santana, M. J. (2021). Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. American Journal of Infection Control, 49(2), 238–246. https://doi.org/10.1016/j.ajic.2020.06.213

Blagosklonny, M. V. (2020). From causes of aging to death from COVID-19. Aging, 12(11), 10004–10021. https://doi.org/10.18632/aging.103493

Casas-Deza, D., Bernal-Monterde, V., Aranda-Alonso, A. N., Montil-Miguel, E., Julián-Gomara, A. B., Letona-Giménez, L., & Arbones-Mainar, J. M. (2021). Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes. PLOS ONE, 16(12), e0261061. https://doi.org/10.1371/journal.pone.0261061

CDC COVID-19 Response Team. (2020). Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR. Morbidity and Mortality Weekly Report, 69(12), 343–346. https://doi.org/10.15585/mmwr.mm6912e2

Cevik, M., Kuppalli, K., Kindrachuk, J., & Peiris, M. (2020). Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ (Clinical Research Ed.), 371, m3862. https://doi.org/10.1136/bmj.m3862

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England), 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7

Clark, A., Jit, M., Warren-Gash, C., Guthrie, B., Wang, H. H. X., Mercer, S. W., Sanderson, C., McKee, M., Troeger, C., Ong, K. L., Checchi, F., Perel, P., Joseph, S., Gibbs, H. P., Banerjee, A., Eggo, R. M., & Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. (2020). Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The Lancet. Global Health, 8(8), e1003–e1017. https://doi.org/10.1016/S2214-109X(20)30264-3

Djaharuddin, I., Munawwarah, S., Nurulita, A., Ilyas, M., Tabri, N. A., & Lihawa, N. (2021). Comorbidities and mortality in COVID-19 patients. Gaceta Sanitaria, 35, S530–S532. https://doi.org/10.1016/j.gaceta.2021.10.085

Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., Abosalif, K. O. A., Ahmed, Z., & Younas, S. (2020). COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of Infection and Public Health, 13(12), 1833–1839. https://doi.org/10.1016/j.jiph.2020.07.014

Gray, W. K., Navaratnam, A. V., Day, J., Wendon, J., & Briggs, T. W. R. (2021). Changes in COVID-19 in-hospital mortality in hospitalised adults in England over the first seven months of the pandemic: An observational study using administrative data. The Lancet Regional Health - Europe, 5, 100104. https://doi.org/10.1016/j.lanepe.2021.100104

Hooper, P. L. (2020). COVID-19 and heme oxygenase: novel insight into the disease and potential therapies. Cell Stress and Chaperones, 25(5), 707–710. https://doi.org/10.1007/s12192-020-01126-9

Indonesian Health Ministry. (2020). 13,2 Persen Pasien COVID-19 Yang Meninggal Memiliki Penyakit Hipertensi. https://www.kemkes.go.id/article/print/20101400002/13-2-persen-pasien-covid-19-yang-meninggal-memiliki-penyakit-hipertensi.html

Kang, S.-J., & Jung, S. I. (2020). Age-Related Morbidity and Mortality among Patients with COVID-19. Infection & Chemotherapy, 52(2), 154. https://doi.org/10.3947/ic.2020.52.2.154

Kementerian Kesehatan RI. (2020). Infodatin tetap produktif, cegah, dan atasi Diabetes Melitus 2020. In Pusat Data dan Informasi Kementerian Kesehatan RI (pp. 1–10).

Li, X., Wang, L., Yan, S., Yang, F., Xiang, L., Zhu, J., Shen, B., & Gong, Z. (2020). Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China. International Journal of Infectious Diseases, 94, 128–132. https://doi.org/10.1016/j.ijid.2020.03.053

Matla Ilpaj, S., & Nurwati, N. (2020). Analisis Pengaruh Tingkat Kematian Akibat COVID-19 Terhadap Kesehatan Mental Masyarakat di Indonesia. Focus : Jurnal Pekerjaan Sosial, 3(1), 16–28. https://jurnal.unpad.ac.id/focus/article/view/28123

Mishra, P., Parveen, R., Bajpai, R., Samim, M., & Agarwal, N. B. (2021). Impact of cardiovascular diseases on severity of COVID-19 patients: A systematic review. Annals of the Academy of Medicine Singapore, 50(1), 52–60. https://doi.org/10.47102/annals-acadmedsg.2020367

Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao, Y., Hou, C., Wang, H., Liu, J., Yang, D., Xu, Y., Cao, Z., & Gao, Z. (2020). Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care, 24(1), 1–10. https://doi.org/10.1186/s13054-020-03120-0

Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020). COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology, 17(9), 543–558. https://doi.org/10.1038/s41569-020-0413-9

Parasher, A. (2021). COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgraduate Medical Journal, 97(1147), 312–320. https://doi.org/10.1136/postgradmedj-2020-138577

Perhimpunan Dokter Hipertensi Indonesia. (2021). Konsensus Penatalaksanaan Hipertensi 2021 : Update Konsensus PERHI 2019. Perhimpunan Dokter Hipertensi Indonesia, 1–66.

Rozaliyani, A., Savitri, A. I., Setianingrum, F., Shelly, T. N., Ratnasari, V., Kuswindarti, R., Salama, N., Oktavia, D., Widyastuti, W., & Handayani, D. (2020). Factors Associated with Death in COVID-19 Patients in Jakarta, Indonesia: An Epidemiological Study. Acta Medica Indonesiana, 52(3), 246–254.

Satria, R. M. A., Tutupoho, R. V., & Chalidyanto, D. (2020). Analisis Faktor Risiko Kematian dengan Penyakit Komorbid Covid-19. Jurnal Keperawatan Silampari, 4(1), 48–55. https://doi.org/10.31539/jks.v4i1.1587

WHO. (2020). Coronavirus. https://www.who.int/health-topics/coronavirus#tab=tab_1

WHO. (2022). Indonesia: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/region/searo/country/id/

Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 94, 91–95. https://doi.org/10.1016/j.ijid.2020.03.017

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England), 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3




DOI: https://doi.org/10.18196/ijnp.v7i1.17347

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

IJNP (Indonesian Journal of Nursing Practices) are indexed by:

        

Office:

School of Nursing, Faculty of Medicine and Health Science, Universitas Muhammadiyah Yogyakarta
Siti Walidah Building F3, 4th floor.
JL. Brawijaya, Tamantirto, Kasihan, Bantul, Yogyakarta 55183
Email: IJNP@umy.ac.id
Web: http://journal.umy.ac.id/index.php/ijnp

Creative Commons License
Indonesian Journal of Nursing Practice is licensed under an Attribution 4.0 International (CC BY 4.0) license.

View My Stats